We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
- Cancer/Oncology
-
2. Cancer vaccines
- Dr. Elias Sayour
-
3. The future of blood tests in cancer treatment
- Dr. Isaac Garcia-Murillas
-
5. Artificial intelligence in precision medicine
- Dr. Michael P. Menden
-
6. How liver X receptor regulates intestinal regeneration and tumor growth
- Dr. Srustidhar Das
- Neurology/Neuroscience
-
7. Integrated multimodal cell atlas of Alzheimer’s disease
- Dr. Michael Hawrylycz
-
8. How and why neurons die in Alzheimer's disease?
- Prof. Bart De Strooper
-
9. Restoring glucose metabolism: a new approach to reversing cognitive decline in AD
- Prof. Katrin Andreasson
-
10. Advancing ALS genetics through accessible testing
- Dr. Teresa Fecteau
-
11. MicroRNA as a biomarker for early detection of amyotrophic lateral sclerosis
- Dr. Sandra Banack
- Dr. Paul Alan Cox
- Dr. Rachael Dunlop
-
12. Translational research in amyotrophic lateral sclerosis (ALS)
- Prof. Aaron D. Gitler
-
13. Muscarinic acetylcholine receptor modulation in neurological diseases- Prof. Andrew B. Tobin
- Immunology & Inflammation
-
14. Role of ETS2 in autoimmune and inflammatory diseases
- Dr. James Lee
-
15. Rheumatic diseases and musculoskeletal pain
- Prof. Anisur Rahman
-
16. Decoy-resistant IL18: how engineered E. coli enhances immune responses against tumors- Dr. Rizwan Romee
-
17. Transmembrane domains and the regulation of trogocytosis in T cells
- Dr. Stefano Barbera
- Infectious Diseases/Microbiology
-
20. Elite controllers of HIV: from discovery to future therapies
- Prof. Bruce Walker
-
22. Towards developing a universal influenza vaccine
- Prof. Peter Palese
- Pharmaceutical Sciences
-
23. The state of the art in secondary pharmacology
- Dr. Jean-Pierre Valentin
-
24. The safety, toxicology, and regulation of antibody-drug conjugates
- Dr. Veysel Kayser
-
26. Management of generic drug development: challenges and opportunities
- Mr. Sandeep Patil
-
27. Translational medicine: the risk of failure in delay and how to reduce it
- Prof. Martin Wehling
-
28. The regulation of cell therapy
- Prof. Moutih Rafei
-
29. Scale-up challenges in the production of nanomedicines from lab to industry
- Prof. Dr. Oya Tagit
-
30. Challenges and solutions of scaling up
- Dr. Shaukat Ali
-
32. Using real-world insights on drug interactions to inform drug development
- Dr. Amita Datta-Mannan
-
33. Role of marketing authorization holder in drug safety
- Dr. Raphael Elmadjian Pareschi
- Methods
-
34. The role of preregistration and registered reports in improving research transparency and reproducibility
- Dr. Peter Bonde Ernst-Rasmussen
-
35. Decoding aging: how a proteomic clock predicts mortality and disease across populations
- Dr. M. Austin Argentieri
-
36. MassBank development and future
- Dr. Emma L. Schymanski
-
37. Synthetic whole embryo models and their applications
- Prof. Jacob (Yaqub) Hanna
-
38. Pioneering proteomics: insights on advancements in the science of proteins
- Prof. Ruedi Aebersold
Topics Covered
- Functional genomics
- Autoimmune and inflammatory diseases
- Macrophage
- Gene ETS2
- Transcription factor
Biography
Dr. James Lee is a Clinician Scientist Group Leader at the Francis Crick Institute and a Consultant Gastroenterologist at the Royal Free Hospital. He trained in medicine at the University of Oxford and gained his PhD from the University of Cambridge in 2011 as part of the inaugural Wellcome Trust Clinical PhD Programme. In 2015, he was awarded a Wellcome Trust Intermediate Clinical Fellowship and spent 2 years of this award at Harvard University before returning to the University of Cambridge in 2018 to establish a research group at the newly-opened Cambridge Institute for Therapeutic Immunology and Infectious Disease. He moved to the Crick in 2021 where he leads the Genetic Mechanisms of Disease laboratory – seeking to translate genetic associations into a better understanding of autoimmune and inflammatory disease biology. In 2014, James was named as the inaugural "Young Gastroenterologist of the Year - Clinical and Translational Science" by the British Society of Gastroenterology and has since been awarded the Julia Bodmer Award (European Federation of Immunogenetics, 2017), the Sir Francis Avery-Jones Medal (British Society of Gastroenterology, 2018), the United European Gastroenterology Society Rising Star Award (2018), and a Lister Prize (2021).
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Lee, J. (2025, April 30). Role of ETS2 in autoimmune and inflammatory diseases [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved February 4, 2026, from https://doi.org/10.69645/MBKJ9727.Export Citation (RIS)
Publication History
- Published on April 30, 2025
Financial Disclosures
- Dr. James Lee has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.